Sumio Chono

2.3k total citations
73 papers, 1.9k citations indexed

About

Sumio Chono is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Sumio Chono has authored 73 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 18 papers in Molecular Biology and 17 papers in Pharmaceutical Science. Recurrent topics in Sumio Chono's work include Inhalation and Respiratory Drug Delivery (25 papers), Advanced Drug Delivery Systems (15 papers) and Pneumonia and Respiratory Infections (12 papers). Sumio Chono is often cited by papers focused on Inhalation and Respiratory Drug Delivery (25 papers), Advanced Drug Delivery Systems (15 papers) and Pneumonia and Respiratory Infections (12 papers). Sumio Chono collaborates with scholars based in Japan, United States and China. Sumio Chono's co-authors include Kazuhiro Morimoto, Toshinobu Seki, Leaf Huang, Shyh‐Dar Li, Kohei Togami, Christine C. Conwell, Yoshihiko Tauchi, Hitoshi Tada, Yoshiharu Deguchi and Hiroshi Kanbayashi and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Sumio Chono

69 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumio Chono Japan	23	839	548	447	400	224	73	1.9k
Vibhudutta Awasthi United States	26	1.0k 1.2×	185 0.3×	218 0.5×	649 1.6×	359 1.6×	100	2.2k
Fatemeh Moheimani Australia	13	1.1k 1.3×	234 0.4×	293 0.7×	778 1.9×	532 2.4×	18	2.3k
Marcela A. Morettón Argentina	22	621 0.7×	275 0.5×	521 1.2×	959 2.4×	492 2.2×	51	2.1k
Mafalda Videira Portugal	23	736 0.9×	408 0.7×	336 0.8×	342 0.9×	269 1.2×	46	1.7k
M.E.M. Cruz Portugal	27	752 0.9×	121 0.2×	363 0.8×	392 1.0×	184 0.8×	57	1.9k
Frédéric Lagarce France	30	1.1k 1.3×	174 0.3×	937 2.1×	905 2.3×	451 2.0×	69	2.7k
Nicole Schneider‐Daum Germany	24	543 0.6×	665 1.2×	231 0.5×	333 0.8×	785 3.5×	59	2.4k
Jing Qi China	28	829 1.0×	249 0.5×	133 0.3×	439 1.1×	819 3.7×	66	2.6k
Adam W. G. Alani United States	26	716 0.9×	144 0.3×	537 1.2×	790 2.0×	567 2.5×	53	2.3k
Andrew J. S. Jones United States	26	1.7k 2.0×	184 0.3×	506 1.1×	302 0.8×	201 0.9×	67	2.8k

Countries citing papers authored by Sumio Chono

Since Specialization

Citations

This map shows the geographic impact of Sumio Chono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumio Chono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumio Chono more than expected).

Fields of papers citing papers by Sumio Chono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumio Chono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumio Chono. The network helps show where Sumio Chono may publish in the future.

Co-authorship network of co-authors of Sumio Chono

This figure shows the co-authorship network connecting the top 25 collaborators of Sumio Chono. A scholar is included among the top collaborators of Sumio Chono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumio Chono. Sumio Chono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Togami, Kohei, et al.. (2022). Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib–hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis. European Journal of Pharmaceutics and Biopharmaceutics. 172. 203–212. 10 indexed citations

Togami, Kohei, et al.. (2022). Development of visualization and analysis methods for evaluating intratumoral nanoparticle kinetics for tumor-targeted drug delivery using Förster resonance energy transfer in vivo live imaging and tissue clearing techniques. Journal of Pharmaceutical and Biomedical Analysis. 223. 115127–115127. 4 indexed citations

Togami, Kohei, et al.. (2020). Multiscale Live Imaging Using Förster Resonance Energy Transfer (FRET) for Evaluating the Biological Behavior of Nanoparticles as Drug Carriers. Journal of Pharmaceutical Sciences. 109(12). 3608–3616. 6 indexed citations

Togami, Kohei, et al.. (2019). Evaluation of various tissue-clearing techniques for the three-dimensional visualization of liposome distribution in mouse lungs at the alveolar scale. International Journal of Pharmaceutics. 562. 218–227. 12 indexed citations

Togami, Kohei, et al.. (2017). Inhibitory Effect of Young Barley Grass Extract Powder on Body Weight Increase and Visceral Fat Accumulation in Mice Fed a High-fat diet. 93. 13–18. 1 indexed citations

Togami, Kohei, et al.. (2017). Evaluation of permeability alteration and epithelial–mesenchymal transition induced by transforming growth factor-β1 in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in idiopathic pulmonary fibrosis. Journal of Pharmacological and Toxicological Methods. 86. 19–27. 31 indexed citations

Togami, Kohei, Eri Yamamoto, Shujun Wang, et al.. (2016). Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces. Drug Delivery and Translational Research. 6(5). 565–571. 11 indexed citations

Togami, Kohei, Sumio Chono, & Kazuhiro Morimoto. (2012). Aerosol-Based Efficient Delivery of Clarithromycin, a Macrolide Antimicrobial Agent, to Lung Epithelial Lining Fluid and Alveolar Macrophages for Treatment of Respiratory Infections. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25(2). 110–115. 19 indexed citations

Togami, Kohei, Sumio Chono, Toshinobu Seki, & Kazuhiro Morimoto. (2010). Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. Drug Development and Industrial Pharmacy. 36(7). 861–866. 12 indexed citations

10.

Chono, Sumio, Hirokazu Suzuki, Kohei Togami, & Kazuhiro Morimoto. (2010). Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections. Drug Development and Industrial Pharmacy. 37(4). 367–372. 24 indexed citations

11.

Chono, Sumio, et al.. (2010). Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages. Drug Development and Industrial Pharmacy. 36(1). 102–107. 41 indexed citations

12.

Chono, Sumio, Shyh‐Dar Li, Christine C. Conwell, & Leaf Huang. (2008). An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. Journal of Controlled Release. 131(1). 64–69. 196 indexed citations

13.

Chono, Sumio, et al.. (2008). Efficient Drug Delivery to Alveolar Macrophages and Lung Epithelial Lining Fluid Following Pulmonary Administration of Liposomal Ciprofloxacin in Rats with Pneumonia and Estimation of its Antibacterial Effects. Drug Development and Industrial Pharmacy. 34(10). 1090–1096. 33 indexed citations

14.

Li, Shyh‐Dar, Sumio Chono, & Leaf Huang. (2008). Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA. Molecular Therapy. 16(5). 942–946. 161 indexed citations

15.

Chono, Sumio, et al.. (2007). Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. Journal of Controlled Release. 127(1). 50–58. 124 indexed citations

16.

Seki, Toshinobu, Hiroshi Kanbayashi, Sumio Chono, Yasuhiko Tabata, & Kazuhiro Morimoto. (2007). Effects of a sperminated gelatin on the nasal absorption of insulin. International Journal of Pharmaceutics. 338(1-2). 213–218. 33 indexed citations

17.

Chono, Sumio, Eri Takeda, Toshinobu Seki, & Kazuhiro Morimoto. (2007). Enhancement of the dissolution rate and gastrointestinal absorption of pranlukast as a model poorly water-soluble drug by grinding with gelatin. International Journal of Pharmaceutics. 347(1-2). 71–78. 33 indexed citations

18.

Li, Shyh‐Dar, Sumio Chono, & Leaf Huang. (2007). Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. Journal of Controlled Release. 126(1). 77–84. 129 indexed citations

19.

Chono, Sumio, Yoshihiko Tauchi, & Kazuhiro Morimoto. (2006). Pharmacokinetic Analysis of the Uptake of Liposomes by Macrophages and Foam Cells In Vitro and their Distribution to Atherosclerotic Lesions in Mice. Drug Metabolism and Pharmacokinetics. 21(1). 37–44. 18 indexed citations

20.

Chono, Sumio, Yoshihiko Tauchi, & Kazuhiro Morimoto. (2006). Influence of Particle Size on the Distributions of Liposomes to Atherosclerotic Lesions in Mice. Drug Development and Industrial Pharmacy. 32(1). 125–135. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact